Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
50.30
Dollar change
+0.37
Percentage change
0.74
%
Index- P/E- EPS (ttm)-3.91 Insider Own13.21% Shs Outstand68.46M Perf Week-5.20%
Market Cap3.47B Forward P/E- EPS next Y-3.83 Insider Trans-0.99% Shs Float59.42M Perf Month0.88%
Income-244.56M PEG- EPS next Q-0.98 Inst Own88.30% Short Float14.90% Perf Quarter0.46%
Sales35.93M P/S96.56 EPS this Y-25.11% Inst Trans32.28% Short Ratio17.80 Perf Half Y4.01%
Book/sh10.28 P/B4.89 EPS next Y-2.07% ROA-36.59% Short Interest8.85M Perf Year141.94%
Cash/sh9.17 P/C5.49 EPS next 5Y-8.20% ROE-44.60% 52W Range20.00 - 61.61 Perf YTD82.91%
Dividend Est.- P/FCF- EPS past 5Y-18.50% ROI-34.32% 52W High-18.36% Beta1.12
Dividend TTM- Quick Ratio8.32 Sales past 5Y7.00% Gross Margin- 52W Low151.50% ATR (14)1.75
Dividend Ex-Date- Current Ratio8.32 EPS Y/Y TTM-5.06% Oper. Margin-642.76% RSI (14)44.22 Volatility3.81% 3.31%
Employees229 Debt/Eq0.02 Sales Y/Y TTM-21.33% Profit Margin-680.61% Recom1.00 Target Price87.73
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-242.63% Payout- Rel Volume0.95 Prev Close49.93
Sales Surprise35.70% EPS Surprise-69.73% Sales Q/Q6.70% EarningsOct 31 BMO Avg Volume497.47K Price50.30
SMA20-3.43% SMA50-1.23% SMA2003.34% Trades Volume470,894 Change0.74%
Date Action Analyst Rating Change Price Target Change
Oct-24-24Initiated UBS Buy $72
Mar-28-24Initiated Truist Buy $69
Mar-04-24Reiterated Needham Buy $42 → $65
Nov-02-23Initiated Canaccord Genuity Buy $45
Aug-21-23Initiated TD Cowen Outperform
Aug-02-22Initiated Stifel Buy $38
Feb-11-22Initiated BMO Capital Markets Outperform $45
Feb-10-22Initiated Needham Buy $45
Nov-17-21Resumed Guggenheim Buy $44
Jun-07-21Upgrade Citigroup Neutral → Buy $24 → $31
Oct-31-24 09:25AM
08:08AM
Sep-30-24 08:00AM
Sep-18-24 10:11AM
Sep-17-24 09:00AM
05:15PM Loading…
Sep-14-24 05:15PM
Aug-30-24 01:15AM
Aug-12-24 04:37PM
Aug-06-24 08:00AM
Aug-01-24 05:30PM
04:10PM
Jul-29-24 10:00AM
Jul-24-24 07:00AM
Jul-08-24 08:00AM
Jul-01-24 08:00AM
02:30PM Loading…
Jun-03-24 02:30PM
Jun-02-24 12:30PM
May-29-24 09:30PM
08:00AM
May-28-24 04:01PM
07:00AM
May-27-24 11:37AM
May-24-24 04:05PM
03:41PM
01:31PM
12:00PM
08:47AM
07:16AM
07:01AM
May-23-24 05:00PM
05:00PM Loading…
05:00PM
11:51AM
May-17-24 12:50PM
May-13-24 09:58AM
08:00AM
May-09-24 12:53AM
May-08-24 04:15PM
May-06-24 04:05PM
Apr-26-24 07:58AM
Apr-25-24 10:01AM
Apr-24-24 10:00AM
Apr-08-24 12:00PM
Apr-03-24 08:00AM
Mar-06-24 10:11AM
08:00AM
06:15AM
Mar-05-24 04:30PM
Mar-04-24 08:00AM
Feb-28-24 04:15PM
Feb-20-24 10:00AM
Feb-16-24 03:57AM
Jan-31-24 08:00AM
Jan-09-24 05:07AM
Dec-28-23 09:55AM
Dec-12-23 09:55AM
Dec-05-23 12:00PM
Dec-04-23 12:15PM
Dec-02-23 08:40PM
Nov-26-23 11:05AM
Nov-23-23 09:55AM
Nov-07-23 09:55AM
Nov-02-23 04:12PM
Nov-01-23 08:00AM
Oct-31-23 10:01AM
Oct-26-23 10:02AM
Oct-23-23 07:30AM
Oct-17-23 05:00AM
Oct-15-23 07:58PM
Oct-13-23 09:00AM
Oct-06-23 09:32AM
Sep-11-23 03:45AM
Sep-07-23 07:36PM
Aug-31-23 08:00AM
Aug-21-23 09:44AM
Aug-09-23 09:53PM
04:01PM
Aug-07-23 07:15PM
04:26PM
Jul-28-23 08:00AM
Jul-05-23 04:01PM
Jun-29-23 04:30PM
Jun-28-23 07:35AM
Jun-15-23 07:47AM
May-31-23 08:00AM
May-21-23 03:28PM
May-11-23 12:00PM
May-10-23 09:55AM
May-05-23 10:24AM
May-04-23 08:15PM
04:25PM
May-02-23 10:01AM
May-01-23 10:00AM
Apr-17-23 10:15AM
Apr-14-23 11:10AM
11:10AM
Apr-10-23 10:16AM
Mar-14-23 04:30PM
04:30PM
09:08AM
Feb-28-23 04:25PM
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shuman HarryVP Controller, PAOAug 21 '24Sale54.002,500135,0007,002Aug 22 04:03 PM
Shuman HarryVP Controller, PAOAug 20 '24Sale54.002,500135,0007,002Aug 22 04:03 PM
Silverman Peter B.COO & GCJun 27 '24Option Exercise17.9410,000179,40010,000Jun 28 04:05 PM
Silverman Peter B.COO & GCJun 27 '24Sale60.0010,000600,0000Jun 28 04:05 PM
Silverman Peter B.COO & GCJun 17 '24Option Exercise24.3662,0001,510,28062,000Jun 20 04:30 PM
Silverman Peter B.COO & GCJun 17 '24Sale56.5262,0003,504,1780Jun 20 04:30 PM
Shuman HarryVP Controller, PAOJun 12 '24Sale57.847,300422,2327,002Jun 12 05:02 PM
Shuman HarryVP Controller, PAOJun 10 '24Sale53.221,00053,2247,002Jun 12 05:02 PM
Shuman HarryVP Controller, PAOJun 04 '24Sale52.896,000317,3547,002Jun 06 04:05 PM
Shuman HarryVP Controller, PAODec 19 '23Sale26.681153,0687,002Dec 20 04:05 PM
Silverman Peter B.COO & GCDec 15 '23Sale25.0022,386559,6500Dec 18 05:15 PM
Shuman HarryVP Controller, PAODec 08 '23Sale24.442506,1107,117Dec 12 04:04 PM
Shuman HarryVP Controller, PAODec 01 '23Option Exercise0.002,50007,942Dec 04 04:05 PM
Shuman HarryVP Controller, PAODec 01 '23Sale24.5857514,1337,367Dec 04 04:05 PM